Ivanhoé Cambridge announced its investment in an 850,000-square-foot life sciences portfolio in India. The portfolio of R&D office and laboratory space in Hyderabad’s “Genome Valley” will be acquired alongside Lighthouse Canton, the existing asset manager with a track record of managing the portfolio with an experienced on-the-ground management team.
India is an established pharma and life sciences innovation hub for global and domestic companies and the world’s largest vaccine manufacturing destination, characterized by a technically sound talent pool and world-class R&D capabilities. Genome Valley is India’s first master-planned cluster for life sciences R&D activities, with India’s largest concentration of multi-tenant lab space. It offers a deep life sciences ecosystem and a synergistic environment facilitating infrastructure sharing, technical collaboration, and access to a world class pool of scientists. The portfolio is occupied by more than 2
